151751-Najiba-Chargi

351 Systemic therapy: skeletal muscle mass and functional outcomes REFERENCES 1. Chaturvedi AK, Anderson WF, Lortet-Tieu - lent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal can- cers. J Clin Oncol . 2013;31(36):4550-4559. doi:10.1200/JCO.2013.50.3870 2. Kreeft A, Tan IB, van den Brekel MWM, Hilgers FJ, Balm AJM. The surgical dilem - ma of ‘functional inoperability’ in oral and oropharyngeal cancer: current consensus on operability with regard to functional re- sults. Clin Otolaryngol . 2009;34(2):140-146. doi:10.1111/j.1749-4486.2009.01884.x 3. Lazarus C, Logemann JA, Pauloski BR, et al. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. HeadNeck . 2007;29(7):632-637. doi:10.1002/ hed.20577 4. Hutcheson KA, Lewin JS, Barringer DA, et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer . 2012;118(23):5793-5799. doi:10.1002/ cncr.27631 5. Mehanna H, Robinson M, Hartley A, et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-posi- tive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet . 2019;393(10166):51-60. doi:10.1016/S0140-6736(18)32752-1 6. Gillison ML, Trotti AM, Harris J, et al. Ra - diotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyn- geal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferior- ity trial. Lancet . 2019;393(10166):40-50. doi:10.1016/S0140-6736(18)32779-X 7. Wall LR, Ward EC, Cartmill B, Hill AJ. Phys - iological changes to the swallowing mech- anism following (chemo)radiotherapy for head and neck cancer: A systematic review. Dysphagia . 2013;28(4):481-493. doi:10.1007/ s00455-013-9491-8 8. Grant S, Kamal M, Mohamed ASR, et al. Sin - gle-item discrimination of quality-of-life– altering dysphagia among 714 long-term oropharyngeal cancer survivors: Compari- son of patient-reported outcome measures of swallowing. Cancer . 2019;125(10):1654- 1664. doi:10.1002/cncr.31957 9. Starmer HM, Tippett D, Webster K, et al. Swallowing outcomes in patients with oro- pharyngeal cancer undergoing organ-pres- ervation treatment. In: Head and Neck . Vol 36. John Wiley and Sons Inc.; 2014:1392- 1397. doi:10.1002/hed.23465 10. Hunter KU, Schipper M, Feng FY, et al. Toxic - ities affecting quality of life after chemo-IM - RT of oropharyngeal cancer: Prospective study of patient-reported, observer-rated, and objective outcomes. Int J Radiat Oncol Biol Phys . 2013;85(4):935-940. doi:10.1016/j. ijrobp.2012.08.030 11. Van Der Molen L, HeemsbergenWD, De Jong R, et al. Dysphagia after chemoradiotherapy Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; Dose-effect relationships for swallowing and mastication structures. Radiother Oncol . 2013;106(3):364-369. doi:10.1016/j.radonc.2013.03.005 12. Lindblom U, Gärskog O, Kjellén E, et al. Ra - diation-induced trismus in the ARTSCAN head and neck trial. Acta Oncol (Madr) . 2014;53(5):620-627. doi:10.3109/028418 6X.2014.892209 13. van der Geer SJ, Kamstra JI, Roodenburg JLN, et al. Predictors for trismus in patients receiving radiotherapy. Acta Oncol (Madr) . 2016;55(11):1318-1323. doi:10.1080/02841 86X.2016.1223341 17